Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration-Reference-Cited by-同舟云学术

Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration

Published:2023-05-13 Issue:5 Volume:30 Page:748-757
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Khalid Freeha,Takagi Kiyoshi^ORCID,Sato Ai,Yamaguchi Mio,Guestini Fouzia,Miki Yasuhiro,Miyashita Minoru,Hirakawa Hisashi,Ohi Yasuyo,Rai Yoshiaki,Sagara Yasuaki,Sasano Hironobu,Suzuki Takashi

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12282-023-01467-0.pdf

Reference39 articles.

1. Zhu Y, Zhu X, Tang C, Guan X, Zhang W. Progress and challenges of immunotherapy in triple-negative breast cancer. Biochim Biophys Acta Rev Cancer. 2021;1876: 188593. https://doi.org/10.1016/j.bbcan.2021.188593.

2. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–21. https://doi.org/10.1111/j.1365-2567.2009.03240.x.

3. Chen X, Wan J, Liu J, Xie W, Diao X, Xu J, et al. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer. 2010;69:348–54. https://doi.org/10.1016/j.lungcan.2009.11.013.

4. Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011;407:348–54. https://doi.org/10.1016/j.bbrc.2011.03.021.

5. Liu X, Jin H, Zhang G, Lin X, Chen C, Sun J, et al. Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PLoS ONE. 2014;9: e106834. https://doi.org/10.1371/journal.pone.0106834.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor (TLR) 4 is a potent prognostic factor in prostate cancer associated with proliferation and invasion;Pathology - Research and Practice;2024-08

2. Clinicopathological Significance and Prognostic Role of High Mobility Group Box 1 (HMGB1), Toll-Like Receptor (TLR) 2 and TLR4 in Breast Cancer;ACTA HISTOCHEMICA ET CYTOCHEMICA;2024-04-25

3. Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer;BMC Immunology;2024-03-21

4. Immune cell networking in solid tumors: focus on macrophages and neutrophils;Frontiers in Immunology;2024-02-14

5. The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential;Discover Oncology;2024-01-20